Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new windowYouTube page opens in new window
[email protected]+61 3 9692 7222
PharmAust (PAA)
Cancer Therapeutics Research
PharmAust (PAA)
  • HOME
  • ABOUT
    • Board
    • Management
    • Corporate Directory
  • PIPELINES & TRIALS
    • Monepantel for Motor Neurone Disease
    • Publications
  • INVESTOR HUB
    • ASX Announcements
    • Annual Reports
    • Investor Presentations
    • Analyst Reports
    • Financial Reports
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Videos
    • Media
  • CONTACT
  • HOME
  • ABOUT
    • Board
    • Management
    • Corporate Directory
  • PIPELINES & TRIALS
    • Monepantel for Motor Neurone Disease
    • Publications
  • INVESTOR HUB
    • ASX Announcements
    • Annual Reports
    • Investor Presentations
    • Analyst Reports
    • Financial Reports
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Videos
    • Media
  • CONTACT

Author Archives: PharmAust

Letter to Shareholder

News & Announcements 2019By PharmAust19/02/2019

190219_Letter to Shareholder

Letter to Optionholder

News & Announcements 2019By PharmAust18/02/2019

190218_Letter to Optionholder

Section 708A

Financial Reports 2019, News & Announcements 2019By PharmAust18/02/2019

190218_Section 708A

Non-renounceable Rights Offer

News & Announcements 2019By PharmAust18/02/2019

190218_Non-renounceable rights offer

DNDi Contract Extension

News & Announcements 2019By PharmAust18/02/2019

190218_DNDi_Extension

Appendix 3B

Financial Reports 2019, News & Announcements 2019By PharmAust18/02/2019

190218_Appendix 3B

Appendix 3B Amendment

Financial Reports 2019, News & Announcements 2019By PharmAust14/02/2019

190214_Appendix 3B Amendment

Monepantel Tablet Taste Masking Test Successfully Completed

News & Announcements 2019By PharmAust10/02/2019

190211_taste_test

Section 708A

Financial Reports 2019, News & Announcements 2019By PharmAust07/02/2019

190207_Section 708A

Appendix 3B

Financial Reports 2019, News & Announcements 2019By PharmAust07/02/2019

190207_Appendix 3B

←1
2345678910111213141516171819202122232425
…2627282930…
313233343536373839404142434445464748495051
52→
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER

PharmAust Follow

PharmAust is a clinical-stage biotech company focused on repurposing monepantel (MPL) for human neurodegenerative diseases ASX: $PAA FSE: $ECQ

PharmAust
pharmaust PharmAust @pharmaust ·
24 Jun

📸 Highlights from the MND Australia Global Day Event at Parliament House!

We teamed up with FightMND to raise awareness and fight for a future free of Motor Neurone Disease. 💙

#MNDAustralia #FightMND #MNDGlobalDay

Reply on Twitter 1805134834358210569 Retweet on Twitter 1805134834358210569 2 Like on Twitter 1805134834358210569 12 Twitter 1805134834358210569
Retweet on Twitter PharmAust Retweeted
stockheadau Stockhead @stockheadau ·
21 Jun

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.
#ASX @PharmAust

Reply on Twitter 1803984607676654065 Retweet on Twitter 1803984607676654065 1 Like on Twitter 1803984607676654065 3 Twitter 1803984607676654065
pharmaust PharmAust @pharmaust ·
21 Jun

Exciting news for our investors! 🎉 Check out the details of our latest capital raise here: https://investorhub.pharmaust.com/investment-offer/32. Thank you for your continued support! 🌟 #PharmAust

Reply on Twitter 1804030728956711230 Retweet on Twitter 1804030728956711230 2 Like on Twitter 1804030728956711230 7 Twitter 1804030728956711230
Load More

Copyright © 2024 PharmAust. All rights reserved.
nil

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top